General Info

Dean M. Wingerchuk, M.D., is a neurologist and clinical epidemiologist with specialty expertise in neuroimmunology. He is the director of the Mayo Clinic Division of Multiple Sclerosis and Autoimmune Neurology. His clinical focus includes: Multiple sclerosis Neuromyelitis optica spectrum disorder (NMO/NMOSD; Devic's disease) Transverse myelitis Optic neuritis Acute disseminated encephalomyelitis (ADEM) Myelopathies (spinal cord syndromes) Other CNS inflammatory diseases Dr. Wingerchuk is the principal investigator for several research trials of treatments of both neuromyelitis optica and multiple sclerosis, and he studies diagnosis, symptoms and outcomes of these diseases. Dr. Wingerchuk is also active in medical student and resident education and is the director of the Mayo Clinic Arizona Evidence-Based Research, Training, and Informatics (MERIT) Center, which focuses on teaching and application of evidence-based medicine principles to neurological clinical practice and research.